Cart
sales@molnova.com
DMeOB
CAS No. 40252-74-2
DMeOB( —— )
Catalog No. M33845 CAS No. 40252-74-2
DMeOB (3,3'-Dimethoxybenzaldazine) is a negative regulator with mGluR5 agonist activity and can be used to study neurological diseases.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 48 | In Stock |
|
| 2MG | 29 | In Stock |
|
| 5MG | 46 | In Stock |
|
| 10MG | 73 | In Stock |
|
| 25MG | 148 | In Stock |
|
| 50MG | 230 | In Stock |
|
| 100MG | 368 | In Stock |
|
| 200MG | 538 | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameDMeOB
-
NoteResearch use only, not for human use.
-
Brief DescriptionDMeOB (3,3'-Dimethoxybenzaldazine) is a negative regulator with mGluR5 agonist activity and can be used to study neurological diseases.
-
DescriptionDMeOB is an agonist ofmGluR5 receptor with an IC50 of 3 μM. DMeOB has a negative modulatory effect.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayNeuroscience
-
TargetGluR
-
RecptorGluR
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number40252-74-2
-
Formula Weight268.31
-
Molecular FormulaC16H16N2O2
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESN(N=CC=1C=CC=C(OC)C1)=CC=2C=CC=C(OC)C2
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. O'Brien JA, et al. A family of highly selective allosteric modulators of the metabotropic glutamate receptor subtype 5. Mol Pharmacol. 2003 Sep;64(3):731-40.?
molnova catalog
related products
-
(S)-MCPG
(S)-MCPG ((+)-MCPG) is a class I/II metabotropic glutamate receptors (mGluRs) antagonist that blocks spatial learning and long-term enhancement of the dentate gyrus in vivo in rats, and can be used to study neurological disorders.
-
TCN 238
TCN 238 is an orally bioavailable positive allosteric modulator of the metabotropic glutamate receptor 4 (mGluR4with an EC50 of 1 μM).
-
(S)-4CPG
(S)-4CPG ((S)-4-Carboxyphenylglycine) is a competitive mGlu1 receptor antagonist that attenuates nociceptive hypersensitivity and nociceptive abnormalities associated with sciatic nerve constriction injuries in rats, and may be used in the study of neurological disorders.
